Literature DB >> 17964794

Novel imidazo[1,2-a]pyrazine derivatives as potent reversible inhibitors of the gastric H+/K+-ATPase.

Peter Jan Zimmermann1, Christof Brehm, Wilm Buhr, Andreas Marc Palmer, Jürgen Volz, Wolfgang-Alexander Simon.   

Abstract

A series of novel 6-substituted imidazo[1,2-a]pyrazines were synthesized via palladium catalyzed amino- or alkoxycarbonylation as key step. The anti-secretory activity of these compounds has been assessed in a binding assay against H(+)/K(+)-ATPase from hog gastric mucosa. Some of the compounds proved to be potent inhibitors of the gastric acid pump.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964794     DOI: 10.1016/j.bmc.2007.09.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  A Quantitative Structure-Activity Relationship and Molecular Modeling Study on a Series of Heteroaryl- and Heterocyclyl-Substituted Imidazo[1,2-a]Pyridine Derivatives Acting as Acid Pump Antagonists.

Authors:  Neeraj Agarwal; Anubha Bajpai; Satya P Gupta
Journal:  Biochem Res Int       Date:  2013-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.